Plasmolifting as a method of choice in the treatment of atrophic vaginitis in menopausal women

Authors

  • S.S. Alimbaeva
  • G.K. Manabaeva

DOI:

https://doi.org/10.37800/RM2021-2-5

Keywords:

plasmolifting, estrogen-deficient states, perimenopause, atrophic vaginitis

Abstract

This study, carried out in the gynecological center «Zhamilya» (Semey, Kazakhstan), shows the effect of using the plasmolifting method in women in the climacteric state with symptoms of atrophic vaginitis.

References

Савельева Е. Менопауза и климакс. Советы гинеколога тем, кому за 40. С-Пб, - 2010, - 128 с.

Шульц К. Р. Менопауза, 1998

Ахмеров Р. Р. Регенеративная медицина на основе аутологичной плазмы. Технология Plasmolifting. — М.: Литерра, 2014. — 160 с.

Ахмеров Р.Р. Регенеративная медицина на основе аутологичной плазмы. Технология Plasmolifting TM.

Cardozo L., In: Birkbauser M. H., Rozenbaum H., eds. Menopause. European Consensus Development Conference. Montreux, Switzerland, 8-10 September. 1995. Paris: Editions Eska, 1996: 59-66

Caspard U. J., Gottal J., van den Brule F. A. Maturitas 1995; 21:171- 178 van Seumeren J. Maturitas, 2000; 34 (Suppl. 1): S3-S8

Astrotbmann H. P. G. Scbneider. Climacteric 2003; 6: 337-346

Writting Group for the Womens Health Initiative Investigators. JAMA 2002; 288: 321-33.

Ромащенко О.В. и др. Формирование сексуальных дисфункций у женщин в постменопаузе и подходы к их устранению. Медичні аспекти здоров’я жінки № 3 (132), 2020.

Кобзарь Н.Н. Приверженность врачей в Республике Казахстан к заместительной гормональной терапии при лечении климактерического синдрома. Репродуктивная медицина. -2(19), - 2014.

Additional Files

Published

2021-07-01

How to Cite

[1]
Alimbaeva С. and Manabaeva Г. 2021. Plasmolifting as a method of choice in the treatment of atrophic vaginitis in menopausal women. Reproductive Medicine (Central Asia). 2 (47) (Jul. 2021), 57–60. DOI:https://doi.org/10.37800/RM2021-2-5.

Issue

No. 2 (47) (2021): Reproductive medicine

Section

Статьи

License

The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.